Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial

Blood (2017) 130 (4): 537–541.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals